Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.73
+0.33000.34%
Post-market: 97.500.7700+0.80%19:59 EDT
Volume:1.18M
Turnover:114.23M
Market Cap:24.30B
PE:-12.44
High:97.90
Open:96.77
Low:96.00
Close:96.40
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:1.33
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.18
PE(LYR):-17.53

Loading ...

OverviewCompanyNewsFilings

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why

TIPRANKS
·
Aug 29

Cevumeran trial termination a ‘clear setback’ for BioNTech, says BMO Capital

TIPRANKS
·
Aug 29

U.S. Stocks on the MOVE-Halliburton, BioNTech, Kazia Therapeutics

Reuters
·
Aug 29

Top Midday Stories: Warsh Says Inflation Data 'Concerning'; Advent, Stripe Drop $50 Billion Bid to Buy PayPal

MT Newswires Live
·
Aug 28

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Aug 28

mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley

TIPRANKS
·
Aug 28

Market Movers | GAP Jumps 18%; Affirm Jumps 14%; IREN Stock Drops 7%; Rubrik Falls 6%; BioNTech Falls 9%

Tiger Newspress
·
Aug 28

BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review

TIPRANKS
·
Aug 28

Movement Alert｜BioNTech SE Falls 8.22% in Regular Trading, Terminates Phase 2 Cancer Immunotherapy Trial While COVID Vaccine Approval Narrows

Market Focus
·
Aug 28

BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer

MT Newswires Live
·
Aug 28

BioNTech to Terminate Mid-Stage Trial of MRNA Cancer Vaccine

Reuters
·
Aug 28

Movement Alert｜BioNTech SE Falls 11.62% in Pre-Market Trading, COVID-19 Vaccine Approved but Eligible Population Sharply Narrowed

Market Focus
·
Aug 28

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Dow Jones
·
Aug 28

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

TIPRANKS
·
Aug 28

Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults

Reuters
·
Aug 28

Is BioNTech (BNTX) Priced Too Richly For Its Lung Cancer Promise?

Simply Wall St.
·
Aug 26

Warburg Research Remains a Hold on Deutsche Euroshop (0I3Z)

TIPRANKS
·
Aug 26

Leonteq revamps board and faces shareholder push on share buyback and director pay

TIPRANKS
·
Aug 25
More